Transcription of 15 mcg*/2 mL - BROVANA
{{id}} {{{paragraph}}}
Example: biology
15 mcg*/2 mL - BROVANA
DOSAGE FORMS AND STRENGTHS. Inhalation Solution (unit-dose vial for nebulization): 15 mcg/2 mL solution (3). CONTRAINDICATIONS. BROVANA Inhalation Solution is contraindicated in patients with a history of hypersensitivity to arformoterol, racemic formoterol or to any other components of this product. (4). Use of a LABA, including BROVANA Inhalation Solution, without an inhaled 15 mcg*/2 mL corticosteroid is contraindicated in patients with asthma . (4). *potency expressed as arformoterol WARNINGS AND PRECAUTIONS. LABA as monotherapy (without an inhaled corticosteroid) for asthma increases the risk of serious asthma -related events. ( ). PRESCRIBING INFORMATION Do not initiate BROVANA Inhalation Solution in acutely deteriorating patients.
LABA (salmeterol) with placebo, each added to usual asthma therapy, showed an increase in asthma-related deaths in patients receiving salmeterol (13/13,176 in patients treated with salmeterol vs. 3/13,179 in patients treated with placebo; RR 4.37, 95% CI 1.25, 15.34). The increased risk of asthma-related death is considered a class effect of
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: